Outcome of the Meeting of Board of Directors held on 29th May, 2025 Consideration and Approval of Audited Financial Result for the half yearly and year ended 31st March, 2025 and Other Matters.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The board of Achyut Healthcare met on 29 May 2025 and approved audited financial results for FY ended 31 March 2025. Revenue from operations fell sharply to ₹304.75 lakhs from ₹613.69 lakhs in FY24, a drop of roughly 50% year-on-year, though net profit rose modestly to ₹54.77 lakhs from ₹50.23 lakhs helped by higher other income. The statutory auditors (Doshi Doshi & Co.) issued an unmodified opinion, and M/s. Mohta Khetawat & Co. was appointed as Internal Auditor for FY26 while Kamlesh M Shah & Co. was appointed as Secretarial Auditor for a 5-year term. The company also approved related party transactions for the half-year ended 31 March 2025 and authorized them for FY26, and confirmed there was no deviation in the use of public issue and preferential issue proceeds.
The steep revenue decline alongside broadly flat profit and deeply negative operating cash flow (₹406 lakhs used in operations) is a concern for shareholders, even though earnings stayed positive and the audit opinion is clean. Investors should watch whether the revenue slump reflects timing or a structural weakness in the pharmaceutical trading business, and monitor the pending AGM and related party transactions for any governance flags.